AZD5863

· AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD5863, covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]